Syed, N., Chavan, S., Sahasrabuddhe, N. A., Renuse, S., Sathe, G., Nanjappa, V., . . . Chatterjee, A. (2015). Silencing of high-mobility group box 2 (HMGB2) modulates cisplatin and 5-fluorouracil sensitivity in head and neck squamous cell carcinoma. Proteomics.
Chicago Style CitationSyed, Nazia, et al. "Silencing of High-mobility Group Box 2 (HMGB2) Modulates Cisplatin and 5-fluorouracil Sensitivity in Head and Neck Squamous Cell Carcinoma." Proteomics 2015.
Cita MLASyed, Nazia, et al. "Silencing of High-mobility Group Box 2 (HMGB2) Modulates Cisplatin and 5-fluorouracil Sensitivity in Head and Neck Squamous Cell Carcinoma." Proteomics 2015.
Atenció: Aquestes cites poden no estar 100% correctes.